
Arrhythmotech LLC, which was launched through the Spin Up program at Indiana University Research and Technology Corp., has received a two-year STTR Phase II grant worth $1,472,476 from the National Institutes of Health.
Dr. Peng-Sheng Chen, company co-founder, said the grant will be used on new methods to study patients who are affected by atrial fibrillation.

“The grant will allow us to collaborate with investigators at the Mayo Clinic in Rochester, Minnesota, and at Cedars-Sinai Medical Center in Los Angeles,” he said.
More information about the NIH grant and how Arrhythmotech will benefit is here.
Leave a Reply